Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Surmodics Inc (NQ: SRDX )

37.53 +0.03 (+0.09%)
Streaming Delayed Price Updated: 1:21 PM EDT, Oct 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Surmodics Inc

< Previous 1 2 3 4 5 6 Next >
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Surmodics, Inc. (SRDX) Investigation
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
SRDX EQUITY ALERT: Rosen Law Firm Encourages Surmodics Inc. Investors to Inquire About Securities Class Action Investigation – SRDX
From Rosen Law Firm
Via Business Wire
Dow Drops 150 Points; Crude Oil Up 1%
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 150 points on Thursday. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  On Thursday, 29 stocks made new 52-week lows. 
Via Benzinga
Surmodics Stock Slides Following Regulatory Setback For Its SurVeil Drug-Coated Balloon
Via Benzinga
Surmodics: Q3 Earnings Insights
  Surmodics (NASDAQ:SRDX) reported its Q3 earnings results on Wednesday, July 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Why Jupiter Wellness Shares Are Trading Lower By Around 40%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Genius Group Limited (NYSE: GNS) jumped 87% to $1.00. Genius Group authorized issue of special dividend and appointed Timothy Murphy to lead Illegal Trading Task Force. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Nasdaq Down Over 100 Points; Procter & Gamble Posts In-Line Earnings
U.S. stocks traded lower midway through trading, with the Dow Jones dropping around 300 points on Thursday. 
Via Benzinga
Recap: Surmodics Q2 Earnings
Surmodics (NASDAQ:SRDX) reported its Q2 earnings results on Wednesday, April 27, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Dow Falls 200 Points; Jobless Claims Drop To 4-Month Low
U.S. stocks traded lower this morning, with the Dow Jones dropping around 200 points on Thursday. 
Via Benzinga
Differentiated Capabilities of Surmodics’ Crystalline Drug Release Platform for Sirolimus-Coated Balloons Presented at ISET Conference
From Surmodics, Inc.
Via Business Wire
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Surmodics Provides Regulatory Update Related to its FDA Premarket Approval Application for the SurVeil™ Drug-Coated Balloon
From Surmodics, Inc.
Via Business Wire
Surmodics Announces SWING Trial 12-Month Data to be Presented at ISET Conference on January 18
From Surmodics, Inc.
Via Business Wire
Surmodics Announces 12-Month Data from the SWING Trial Presented at VEITHsymposium
From Surmodics, Inc.
Via Business Wire
Surmodics Announces SWING Trial 12-Month Data to be Presented at VEITHsymposium on November 16
From Surmodics, Inc.
Via Business Wire
Surmodics Reports Fourth Quarter and Fiscal Year 2022 Financial Results; Introduces Fiscal Year 2023 Financial Guidance
From Surmodics, Inc.
Via Business Wire
24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference
From Surmodics, Inc.
Via Business Wire
Surmodics to Report Fourth Quarter and Fiscal Year 2022 Financial Results on November 9th
From Surmodics, Inc.
Via Business Wire
Surmodics Announces TRANSCEND Trial 24-Month Data to be Presented at VIVA 2022
From Surmodics, Inc.
Via Business Wire
Surmodics Announces New Credit Facilities Providing up to $125 Million in Financing
From Surmodics, Inc.
Via Business Wire
6-Month Data from the Surmodics SWING BTK First-in-Human Trial Presented at AMP Europe
From Surmodics, Inc.
Via Business Wire
6-Month Data from the Surmodics SWING First-in-Human Study to be Presented at AMP Europe
From Surmodics, Inc.
Via Business Wire
Surmodics to Present at Upcoming Gilmartin Emerging Growth Company Showcase Wednesday, August 31, 2022
From Surmodics, Inc.
Via Business Wire
Surmodics Reports Third Quarter Fiscal 2022 Results
From Surmodics, Inc.
Via Business Wire
A Preview Of Surmodics's Earnings
Surmodics (NASDAQ:SRDX) is set to give its latest quarterly earnings report on Wednesday, 2022-07-27. Here's what investors need to know before the announcement. Analysts estimate that Surmodics will... 
Via Benzinga
Earnings Scheduled For July 27, 2022
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report earnings for its second quarter. 
Via Benzinga
Surmodics to Webcast Third Quarter Fiscal 2022 Earnings Conference Call on July 27
From Surmodics, Inc.
Via Business Wire
Surmodics to Present at Jefferies Healthcare Conference
From Surmodics, Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.